Boldly leading a global effort to find cures for multiple sclerosis is no small undertaking, but thanks to the transformational support of a special group of philanthropic leaders, we’re off to a powerful start. With collective gifts totaling $12 million, the Pathways to Cures Lead Investors featured below are putting their mark on an MS cure by helping establish the early momentum needed to rally the world.
Jim and Kathleen Skinner
“A complex disease like MS requires an organization that is in touch with people who have the disease and what they want in their lives — this is apparent in the Pathways to Cures plan. Cures are described clearly, and the discoveries needed to achieve each cure are laid out. We are pleased to be at the front of this incredible work and have confidence that the National MS Society has what it takes to provide leadership in the global MS movement.”
Laura Larson
“I've always been grateful for the Society’s warmth when MS turned my life upside down. Its programs taught me what was going on inside my body, taught me coping skills and connected me with others who had MS. Most of all, it gave me hope that there WAS a cure, just waiting to be found. The discoveries since my diagnosis nearly 30 years ago have been astounding, and we are very close to unlocking the remaining secrets of MS. I want to help us get there. The reason I donate to the National MS Society is simple ... so one day no one will hear the words my doctor said to me.”
Bill and Cathy Onufrychuk
“We have been actively involved with the National MS Society for 28 years and have never been as optimistic about the potential for real progress toward our goal of finding cures for MS. With the advances in science and technology along with the commitment of some of the most noted researchers in the world, NOW is the time to go big so that we can do our part to end MS forever.”
The Goodyear Family
“We have always been impressed with the extensive growth over the years of the Society’s programs to help people with MS and its work with researchers and pharmaceutical companies leading to an ever increasing number of MS drugs. The Society’s leadership in International Research has also had a significant impact on the road to a cure. We believe that the end is in sight and that Pathways to Cures is the perfect vehicle for the last stage of the trip.”
Chip and Elizabeth Goodyear (L) & Charles and Linda Goodyear (R)